Select Page

Clinical Research Organizations: M&A Goldmine or Cyber Risk Liability?

The market for clinical trials is experiencing significant momentum in mergers and acquisitions (M&A). Private equity (PE) investment in Clinical Research Organizations (CROs) and Site Management Organizations (SMOs) is being spurred by site consolidation, expansion of specialized services, and technology innovation. These firms are important players in the pipeline of drug development and the best targets for investors who wish to capitalize on healthcare innovation.

read more